TY - JOUR
T1 - SARS-CoV-2 infection and COVID-19 outcomes across mental disorders and the role of sex
T2 - A register-based study from Catalonia
AU - Monistrol-Mula, Anna
AU - Giné-Vázquez, Iago
AU - Caggiu, Giulia
AU - Conflitti, Claudia
AU - Gemes, Katalin
AU - Hecker, Irwin
AU - Mediavilla, Roberto
AU - Monzio Compagnoni, Matteo
AU - Pinucci, Irene
AU - Stoffers-Winterling, Jutta
AU - Witteveen, Anke B.
AU - Smith, Pierre
AU - Walter, Henrik
AU - Ayuso-Mateos, Jose Luis
AU - Melchior, Maria
AU - Mittendorfer-Rutz, Ellenor
AU - Sijbrandij, Marit
AU - Haro, Josep Maria
AU - Felez-Nobrega, Mireia
N1 - Publisher Copyright:
© 2024 The Author(s)
PY - 2024/12/12
Y1 - 2024/12/12
N2 - Introduction: This study investigated the risk of SARS-CoV-2 infection and severe COVID-19 outcomes among different mental health diagnoses and the role of sex in these associations. Methods: Using electronic records from Catalonia, we identified adults receiving mental health care from 2017–2019 with diagnoses of non-affective psychosis (NAP), bipolar disorder (BD), depressive disorder (DEP), stress-related disorders, neurotic/somatoform disorders (NSD), and substance misuse (SUB) (exposed). The outcomes assessed were SARS-CoV-2 infection, COVID-19 hospitalization, and COVID-19-related death, compared to matched individuals without these mental disorders (unexposed). Adjusted logistic regression analyses were conducted. Results: 785,378 adults were included (70.3% < 65 years old; 57.1% women). Compared to unexposed, those with NAP, BD, DEP, and SUB had a lower risk of SARS-CoV-2 infection, while those with NSD had an increased risk. Infected individuals with DEP, NSD, and SUB had a lower risk of hospitalization but a higher risk of COVID-19-related death. Higher COVID-19-related death was also observed in individuals with NAP and BD. Sex-stratified analysis revealed that women with NSD were especially vulnerable to infection, and women with DEP and NSD had a higher risk of COVID-19-related death. Conclusions: These findings emphasize the need for tailored public health strategies to reduce excess mortality risk among individuals with certain mental disorders, while accounting for sex differences.
AB - Introduction: This study investigated the risk of SARS-CoV-2 infection and severe COVID-19 outcomes among different mental health diagnoses and the role of sex in these associations. Methods: Using electronic records from Catalonia, we identified adults receiving mental health care from 2017–2019 with diagnoses of non-affective psychosis (NAP), bipolar disorder (BD), depressive disorder (DEP), stress-related disorders, neurotic/somatoform disorders (NSD), and substance misuse (SUB) (exposed). The outcomes assessed were SARS-CoV-2 infection, COVID-19 hospitalization, and COVID-19-related death, compared to matched individuals without these mental disorders (unexposed). Adjusted logistic regression analyses were conducted. Results: 785,378 adults were included (70.3% < 65 years old; 57.1% women). Compared to unexposed, those with NAP, BD, DEP, and SUB had a lower risk of SARS-CoV-2 infection, while those with NSD had an increased risk. Infected individuals with DEP, NSD, and SUB had a lower risk of hospitalization but a higher risk of COVID-19-related death. Higher COVID-19-related death was also observed in individuals with NAP and BD. Sex-stratified analysis revealed that women with NSD were especially vulnerable to infection, and women with DEP and NSD had a higher risk of COVID-19-related death. Conclusions: These findings emphasize the need for tailored public health strategies to reduce excess mortality risk among individuals with certain mental disorders, while accounting for sex differences.
KW - Electronic health records
KW - Mortality
KW - Psychiatric disorders
KW - Severe COVID-19
KW - Sex
UR - http://www.scopus.com/inward/record.url?scp=85212413293&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85212413293&partnerID=8YFLogxK
U2 - 10.1016/j.psychres.2024.116325
DO - 10.1016/j.psychres.2024.116325
M3 - Article
AN - SCOPUS:85212413293
SN - 0165-1781
VL - 344
SP - 1
EP - 8
JO - Psychiatry Research
JF - Psychiatry Research
M1 - 116325
ER -